De novo hepatitis with autoimmune antibodies and atypical histology: A rare cause of late graft dysfunction after pediatric liver transplantation

Transplantation

Volumn 71, Issue 5, 2001, Pages 664-668

  Gupta, Puneet ^a,b   Hart, John ^a   Millis, J Michael ^a   Cronin, David ^a   Brady, Lynda ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; BILIRUBIN; CYCLOSPORIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN M; MICROSOME ANTIBODY; PREDNISONE; SMOOTH MUSCLE ANTIBODY; STEROID;

ADOLESCENT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; FEMALE; GRAFT FAILURE; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER FIBROSIS; LIVER MICROSOME; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 0035868388     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200103150-00016     Document Type: Article

References (25)

1. Causes of late graft loss after liver transplantation
2. Long-term survival after liver transplantation
3. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation
4. Graft and systemic disease in long-term survivors of liver transplantation
5. De-novo autoimmune hepatitis after liver transplantation
6. Autoantibodies after liver transplantation: A marker of allograft disease
7. De-novo autoimmune hepatitis following liver transplantation in adults: A rare cause of graft rejection and loss
8. Meeting report: International Autoimmune Hepatitis Group
9. Drug therapy in the management of type 1 autoimmune hepatitis
10. Autoimmune hepatitis in childhood: A 20-year experience
11. Incidence, timing, and risk factors for acute and chronic rejection
12. Terminology for hepatic allograft rejection
13. Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease: Possible association with a steroid-resistant transplant rejection episode
14. Allograft rejection after liver transplantation for autoimmune liver diseases
15. Clinicopathologic features of late hepatic dysfunction in orthotopic liver transplants
16. Criteria for the histopathological classification of liver allograft rejection and their clinical relevance
17. Fibrosis/cirrhosis after orthotopic liver transplantation
18. Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus
19. Outcome of autoimmune hepatitis after liver transplantation
20. Recurrence of autoimmune hepatitis in children after liver transplantation
21. Frequency and nature of the variant syndromes of autoimmune liver disease
22. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy
23. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: A randomized placebo-controlled treatment trial
24. Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis
25. Oral budesonide for treatment of autoimmune chronic active hepatitis